This report presents data on mpox cases reported to the European Surveillance System (EpiPulse Cases). EU/EEA countries report case based data to ECDC on diagnosed mpox cases. For case numbers by countries, Western Balkans and Türkiye are included.
This list below shows the current accommodation sites in EU/EEA countries with which clusters of Legionnaires’ disease have been identified but where the European Legionnaires’ disease Surveillance Network (ELDSNet) is unable to assess the risk of Legionella infection, or where ELDSNet believe there may be increased risk to travellers.
The primary EU-level public health objective of the CRECC pilot survey is to determine the occurrence, geographical distribution and population dynamics of high-risk CRECC lineages, and related transmissible genetic elements of public health importance, within healthcare settings in Europe to improve risk assessment and control policies.
Protocol for the carbapenem-resistant Enterobacter cloacae complex (CRECC) pilot survey
English (837.6 KB - PDF)
The aim of the Public Health Emergency Preparedness Assessment, as mandated in Article 8 of Regulation (EU) 2022/2371 on serious cross-border threats to health, is to improve prevention, preparedness and response planning in European Union/European Economic Area (EU/EEA) countries through the implementation of recommendations following individual country assessments.
Country report: ECDC Public Health Emergency Preparedness Assessment for the Czech Republic, 2026
English (1.04 MB - PDF)
Since May 2026, an Ebola virus disease outbreak caused by Bundibugyo virus has been ongoing in the Democratic Republic of the Congo (DRC).
This handbook provides laboratory professionals in the EU/EEA with a comprehensive overview of commonly used laboratory protocols for the characterisation of respiratory syncytial virus (RSV).
Handbook of laboratory protocols for respiratory syncytial virus (RSV) characterisation
English (2.46 MB - PDF)
This issue of the Communicable disease threats report (CDTR) covers the period 3 - 9October 2026, and includes updates on respiratory virus epidemiology in the EU/EEA, pneumonia of unknown aetiology, Ebola, expert deployment, West Nile Virus, Crimean-Congo haemorrhagic fever, dengue, chikungunya, symptomatic Sindbis case in Germany, measles, and Salmonella Strathcona.
Communicable disease threats report, 3 - 9 October, week 41
English (2.64 MB - PDF)
This report gives an overview of the countries and areas where dengue cases – and their corresponding case numbers - have been reported to the European surveillance portal for infectious diseases (EpiPulse).
In the EU/EEA, increased circulation of SARS-CoV-2 is observed, with limited impact on hospitalisations. Respiratory syncytial virus and influenza circulation remain at low levels.
Update providing weekly overview of the countries and areas where chikungunya virus disease cases have been reported.
This interactive dashboard provides a weekly integrated epidemiological summary for influenza, RSV and SARS-CoV-2.
ECDC regularly assesses new evidence on variants detected through epidemic intelligence, rules-based genomic variant screening or other scientific sources.
Weekly updates with the latest reports on West Nile virus cases in Europe updated every Friday, during the transmission season.
Weekly updated overview of reported Crimean-Congo haemorrhagic fever (CCHF) in the EU/EEA countries and areas.
This report provides an overview of measles and rubella cases reported to ECDC through The European Surveillance System (TESSy).
West Nile virus (WNV) infection is a mosquito-borne zoonosis that is endemo-epidemic in Europe.
Highly pathogenic avian influenza A(H5N1) continues to circulate widely in wild birds and cause outbreaks in poultry and other animals across Europe. Despite extensive circulation, human infections remain rare and no human cases have been confirmed in the EU/EEA to date.
Zoonotic influenza A(H5) vaccination in humans in the EU/EEA
English (735.12 KB - PDF)
Following the reported death of a laboratory worker in Irkutsk, Russia, from pneumonia that is suspected to be pneumonic plague, ECDC is closely monitoring the situation.
ECDC provides technical guidelines on the safety and quality of Substances of Human Origin (SoHO) from a communicable disease threat perspective.
Every month ECDC provides detailed epidemiological overview of the worldwide transmission of chikungunya virus disease in its weekly threat report (Communicable Diseases Threat Report).
This case definition was published in Commission Implementing Regulation (EU) 2026/2097, which lists the diseases and health issues under EU surveillance.
ECDC offers a 5-9 month traineeship programme targeted towards graduates who are at the beginning of their professional career.
An EU-led mission of experts to Albania this week will identify priority gaps, define areas for further action and support the strengthening of national responses to antimicrobial resistance (AMR) in the country.
Minutes of the 85th meeting of the ECDC Advisory Forum, via videoconference, 22 May 2026.
85th meeting of the ECDC Advisory Forum, 22 May 2026
English (185.88 KB - PDF)